Is PennantPark PNNT stock worth initiating exposure Q1 2026 Profit Disappoints ACNB ACNB Corp delivers narrow Q1 2026 earnings beat shares fall nearly 3 percent in todays trading session Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings